Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1glp-1semaglutidesmell and tastejama

JAMA Otolaryngology letter flags smell and taste disturbances in GLP-1 users

Danish authors raise concerns about chemosensory side effects among patients taking GLP-1 receptor agonists.

MH
By Maren Holt · Senior Reporter, GLP-1

The wire

  1. 01A research letter in JAMA Otolaryngology–Head & Neck Surgery addresses reports of smell and taste disturbances among GLP-1 receptor agonist users.
  2. 02Clinicians prescribing incretin drugs may need to ask about chemosensory changes, which can affect nutrition and adherence.
  3. 03Only the title and authorship are available here; the magnitude, sample and design of the underlying analysis are not described.

From the source

Concerns About Smell and Taste Disturbances Among GLP-1 Receptor Agonist Users

JAMA otolaryngology-- head & neck surgery · 2026 Oct 22 · Gam-Jensen M, Fjaeldstad AW et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →